TY - JOUR
T1 - Iron-mediated tissue damage in acquired ineffective erythropoiesis disease
T2 - It's more a matter of burden or more of exposure to toxic iron form?
AU - Pilo, Federica
AU - Cilloni, Daniela
AU - Della Porta, Matteo Giovanni
AU - Forni, Gian Luca
AU - Piperno, Alberto
AU - Santini, Valeria
AU - Angelucci, Emanuele
N1 - Funding Information:
Medical writing assistance for the preparation of this article was funded by Novartis Pharma, Italy . The funder was not involved in the writing of this article or the decision to submit it for publication.
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/3
Y1 - 2022/3
N2 - Iron is essential in cellular life, however, when in excess, it favors the production of reactive oxygen species (ROS) that, when overwhelm the physiological cellular antioxidant system, produce an oxidative stress state leading to cellular damages and organ failure. What is not yet completely clear is whether the damage is related more to the amount of iron or to the duration of exposure to ROS. Various cellular pathways are sensitive to the detrimental action of ROS in a non-dose-dependent manner. In addition, different organs have a different capacity to respond to iron-mediated toxicity, suggesting that the toxicity thresholds are disease-specific and patient-dependent. The aim of this article is to review the recent understanding of the concept of exposure to free iron-mediated damage, comprehending the need to design protocols in which reducing organ exposure to ROS is the primary objective in order to prevent or delay the development of organ damage.
AB - Iron is essential in cellular life, however, when in excess, it favors the production of reactive oxygen species (ROS) that, when overwhelm the physiological cellular antioxidant system, produce an oxidative stress state leading to cellular damages and organ failure. What is not yet completely clear is whether the damage is related more to the amount of iron or to the duration of exposure to ROS. Various cellular pathways are sensitive to the detrimental action of ROS in a non-dose-dependent manner. In addition, different organs have a different capacity to respond to iron-mediated toxicity, suggesting that the toxicity thresholds are disease-specific and patient-dependent. The aim of this article is to review the recent understanding of the concept of exposure to free iron-mediated damage, comprehending the need to design protocols in which reducing organ exposure to ROS is the primary objective in order to prevent or delay the development of organ damage.
KW - Iron toxicity
KW - Myelodysplastic syndrome
KW - Reactive oxygen species
UR - http://www.scopus.com/inward/record.url?scp=85123414381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123414381&partnerID=8YFLogxK
U2 - 10.1016/j.leukres.2022.106792
DO - 10.1016/j.leukres.2022.106792
M3 - Review article
AN - SCOPUS:85123414381
SN - 0145-2126
VL - 114
JO - Leukemia Research
JF - Leukemia Research
M1 - 106792
ER -